Seelos Therapeutics, Inc.
SEELDelisted Apr 4, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001017491
Seelos Therapeutics, Inc. was delisted on Apr 4, 2025; its insiders filed their last Form 4 on Mar 1, 2024; 23 institutions reported holding it in 13F filings for Q2 2024, worth $129.4K in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Seelos Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 73 | 105 | +32 |
| Shares | 25.0M | 40.8M | +15.8M (+63.3%) |
| Value | $124.8M | $107.8M | −$17.0M (−13.6%) |
New holders (50)
Institutions that held Seelos Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (18)
Institutions that held Seelos Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 1,446,465 | $7.22M |
| Endurant Capital Management LP | 611,624 | $3.05M |
| Marshall Wace, LLP | 609,013 | $3.04M |
| Asymmetry Capital Management, L.P. | 440,745 | $2.20M |
| Ergoteles LLC | 109,257 | $545.0K |
| Squarepoint Ops LLC | 31,060 | $155.0K |
| Capstone Investment Advisors, LLC | 25,707 | $128.0K |
| Commerce Bank | 25,000 | $125.0K |
| LMR Partners LLP | 23,983 | $120.0K |
| Dorsey Wright & Associates | 10,388 | $51.8K |
| Atlas Private Wealth Advisors | 4,240 | $21.0K |
| Valeo Financial Advisors, LLC | 3,000 | $15.0K |
| Bank of Montreal | 1,839 | $10.0K |
| Total Clarity Wealth Management, Inc. | 2,000 | $10.0K |
| American Portfolios Advisors | 1,000 | $4.99K |
| Wells Fargo & Company | 421 | $2.00K |
| Clearstead Advisors, LLC | 300 | $1.00K |
| TCI Wealth Advisors, Inc. | 200 | $1.00K |